Literature DB >> 26375861

Why therapies for Alzheimer's disease do not work: Do we have consensus over the path to follow?

Zareen Amtul1.   

Abstract

Alzheimer's disease (AD) represents a personal tragedy of enormous magnitude, which imposes a daunting worldwide challenge for health-care providers and society as well. In last five decades, global research in clinics and laboratories has illuminated many features of this sinister and eventually fatal disease. Notwithstanding this development, the Alzheimer's research apparently has come across a phase of disappointment and a little reservation about the direction to follow. Persistently distressing controversies and a significant number of missing facts shed further uncertainty about the path forward. A detailed description of some of the main controversies in AD research may assist the field towards finding a resolution. Here I reviewed some alarming concerns or controversies related to these primary issues and emphasized on a possible mechanism to settle them.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid; Animal models; Inflammation; Oxidative stress; Tau; Vascuar

Mesh:

Year:  2015        PMID: 26375861     DOI: 10.1016/j.arr.2015.09.003

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  9 in total

1.  The Dynamics of Impaired Blood-Brain Barrier Restoration in a Rat Model of Co-morbid Injury.

Authors:  Zareen Amtul; Jun Yang; Simona Nikolova; Ting-Yim Lee; Robert Bartha; David F Cechetto
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

2.  Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Authors:  Kai-C Sonntag; Woo-In Ryu; Kristopher M Amirault; Ryan A Healy; Arthur J Siegel; Donna L McPhie; Brent Forester; Bruce M Cohen
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

Review 3.  Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.

Authors:  Hueng-Chuen Fan; Ching-Shiang Chi; Shin-Nan Cheng; Hsiu-Fen Lee; Jeng-Dau Tsai; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2015-12-25       Impact factor: 5.923

4.  The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study.

Authors:  Laura Cantu'; Laura Colombo; Tatiana Stoilova; Bruno Demé; Hideyo Inouye; Rachel Booth; Valeria Rondelli; Giuseppe Di Fede; Fabrizio Tagliavini; Elena Del Favero; Daniel A Kirschner; Mario Salmona
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

5.  Altered Insulin/Insulin-Like Growth Factor Signaling in a Comorbid Rat model of Ischemia and β-Amyloid Toxicity.

Authors:  Zareen Amtul; David J Hill; Edith J Arany; David F Cechetto
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

6.  Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.

Authors:  Woo-In Ryu; Minqi Shen; Yoon Lee; Ryan A Healy; Mariana K Bormann; Bruce M Cohen; Kai-Christian Sonntag
Journal:  Aging Cell       Date:  2022-06-21       Impact factor: 11.005

7.  Homocysteine fibrillar assemblies display cross-talk with Alzheimer's disease β-amyloid polypeptide.

Authors:  Dorin Sade Yazdi; Dana Laor Bar-Yosef; Hanaa Adsi; Topaz Kreiser; Shahaf Sigal; Santu Bera; Dor Zaguri; Shira Shaham-Niv; Damilola S Oluwatoba; Davide Levy; Myra Gartner; Thanh D Do; Dan Frenkel; Ehud Gazit
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

Review 8.  The Role of Gene Editing in Neurodegenerative Diseases.

Authors:  Hueng-Chuen Fan; Ching-Shiang Chi; Yih-Jing Lee; Jeng-Dau Tsai; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Cell Transplant       Date:  2018-05-16       Impact factor: 4.064

9.  Brain cells derived from Alzheimer's disease patients have multiple specific innate abnormalities in energy metabolism.

Authors:  Woo-In Ryu; Mariana K Bormann; Minqi Shen; Dohoon Kim; Brent Forester; Yeongwon Park; Jisun So; Hyemyung Seo; Kai-C Sonntag; Bruce M Cohen
Journal:  Mol Psychiatry       Date:  2021-04-16       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.